Literature DB >> 7709892

Management of hypercholesterolemia.

G H Blake1, L C Triplett.   

Abstract

As a major risk factor for coronary heart disease, hypercholesterolemia is responsible for a significant number of illnesses and deaths, and contributes considerably to health care costs. Lowering cholesterol levels reduces the risk of coronary heart disease and may halt or reverse atherosclerosis. Lifestyle modifications include dietary measures and aerobic exercise. Pharmacologic therapy can further decrease cholesterol levels. Family physicians need to recognize patients at risk for hypercholesterolemia (and thus coronary heart disease), institute appropriate therapy and counsel family members about disease prevention.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7709892

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  2 in total

Review 1.  Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.

Authors:  K L Goa; L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

2.  Hyperlipidemia and obesity among diabetics at jubail miiltary hospital.

Authors:  K S Al-Ghamdi; R Rehman
Journal:  J Family Community Med       Date:  1998-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.